EUSA names new CEO
This article was originally published in Scrip
EUSA Pharma, a recently established specialty pharmaceutical company, has named Lee Morley CEO and Dr Göran Ando non-executive director. Mr Morley joins EUSA from Jazz Pharmaceuticals, where he was vice-president and head of commercial for Europe and international markets. At Jazz, Mr Morley had responsibility for the original EUSA Pharma business following its acquisition in 2012, until the recent launch of EUSA as a newly established independent company. He has also previously held a number of management positions in sales and marketing at Merck Sharp and Dohme.
You may also be interested in...
A selection of articles you might have missed from August 2020, including exclusive interviews with industry leaders and a review of financing trends.
Rabia Khan, managing director of discovery sciences at Sensyne Health, talks to In Vivo about pairing biology with technology in the most effective way, managing COVID-19 challenges and what the future leaders of biopharma might look like.
Health care funding in the first half of 2020 reached $10.4bn, according to a mid-year report from Silicon Valley Bank, nearly matching 2019’s full-year record. As well as the COVID-19 pandemic though, other global events, such as the US election, could become distractions in the second half of the year.